Supraorbital Basosquamous Carcinoma Treated with Cemiplimab Followed by Sonidegib: A Case Report and Review of the Literature

<i>Basal cell carcinoma</i> (BCC) is a skin cancer with low local aggressiveness and a low tendency to metastasize. <i>Basosquamous Carcinoma</i> (BSC) represents an aggressive histological subtype of BCC with intermediate features between <i>Squamous Cell Carcinoma</i> (SCC) and BCC. Cemiplimab is...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ilaria Proietti, Luca Filippi, Ersilia Tolino, Nicoletta Bernardini, Francesca Svara, Federica Trovato, Claudio Di Cristofano, Vincenzo Petrozza, Oreste Bagni, Andrea Vizzaccaro, Nevena Skroza, Concetta Potenza
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2023-10-01
Edice:	Biomedicines
Témata:	<i>Basal cell carcinoma</i> basosquamous carcinoma <i>Squamous Cell Carcinoma</i> immunotherapy Cemiplimab hedgehog inhibitors
On-line přístup:	https://www.mdpi.com/2227-9059/11/11/2903
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!